Novo Nordisk A/S
The ‘sell America’ trade, Trump arrives in Davos, Netflix earnings and more in Morning Squawk
This is CNBC’s Morning Squawk newsletter. Subscribe here to receive future editions in your inbox. Happy Wednesday. Or maybe not, if you held U.S. assets amid yesterday’s sell-off. S&P 500 futures are little changed this morning. The three major indexes are coming off their worst day in months. Here are five key things investors need to know […]
Read More
Drug pricing, patent losses and deals: Here’s what pharma execs see ahead in the industry
US President Donald Trump arrives for an announcement in the Roosevelt Room of the White House in Washington, DC, US, on Friday, Dec. 19, 2025. Will Oliver | Bloomberg | Getty Images Drug pricing. Looming patent cliffs. Dealmaking. The first year of Trump 2.0. Those are among the themes that dominated conversations last week as drugmakers […]
Read More
CNBC Daily Open: The EU has a nuclear option to deal with Trump’s Greenland tariffs — and is mulling over it
Flags of the European Union fly outside the EU headquarters in Brussels, Belgium, on December 19, 2025. (Photo by Jonathan Raa/NurPhoto via Getty Images) Nurphoto | Nurphoto | Getty Images Greenland’s Prime Minister Jens-Frederik Nielsen stood firm on the island’s self-governance, saying on Monday that the “latest statements from the US, including threats of tariffs, do […]
Read More
Stocks making the biggest moves midday: Novo Nordisk, Vistra, GE Vernova, Regions Financial and more
Check out some of the companies making headlines in midday trading: Novo Nordisk — The maker of the Wegovy obesity treatment jumped more than 4% as sales of its oral weight loss treatment got off to a strong start. In the first week of its launch, about 1.3% of Wegovy prescriptions were for the oral […]
Read More
Novo Nordisk shares rise 5% after Wegovy obesity pill has ‘solid’ launch
A pharmacist displays a box of Wegovy pills at a pharmacy in Provo, Utah, US, on Thursday, Jan. 15, 2026. George Frey | Bloomberg | Getty Images Shares of Novo Nordisk rose more than 5% on Friday after early prescription data showed an encouraging start to the U.S. launch of the company’s new GLP-1 pill […]
Read More
This pharma stock just got whacked — there’s still a major catalyst ahead
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. Stocks were climbing on Thursday led by semiconductors and AI-related names. Taiwan Semiconductor rallied more than 5% after reporting strong fourth quarter results and forecasting higher […]
Read More
Healthy Returns: Novo Nordisk CEO on GLP-1 pricing, and more insights from the JPM conference
A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Good morning from San Francisco! It’s day three of the annual JPMorgan Healthcare Conference – the biggest gathering of biotech and pharma execs, investors and analysts in […]
Read More
Powell’s criminal investigation, Google’s AI shopping push, Boeing deliveries and more in Morning Squawk
This is CNBC’s Morning Squawk newsletter. Subscribe here to receive future editions in your inbox. Happy Monday. I find myself at an impasse trying to decide what to write in this intro. As someone who’s committed to their skincare routine, I should write about this story on the latest men’s beauty trend. But as a Michigan native, […]
Read More
Behind Anthropic’s stunning growth is a sibling team that may hold the key to generative AI
SAN FRANCISCO — Daniela Amodei has an energy that’s hard to place — warm, unhurried, immediately present. She swept into a sunlit room on the ground floor of Anthropic’s headquarters in December, sat down, and immediately apologized for her mug. “Is my, like, gigantic novelty mug going to be distracting if I have it?” she […]
Read More
2026 is the year of obesity pills. Here’s how they could reshape the GLP-1 market
The booming GLP-1 space was built on weekly injections. In 2026, new obesity pills will push the market into its next chapter. Patients are already getting their hands on the first GLP-1 pill for obesity from Danish drugmaker Novo Nordisk — a once-daily drug that shares the same brand name as its popular injection Wegovy. […]
Read More